Generics - Asia-Pacific, Production

Filter

Current filters:

Asia-PacificProduction

Popular Filters

1 to 25 of 29 results

Sun Pharma latest Indian generic drugmaker to fall foul of US FDA

Sun Pharma latest Indian generic drugmaker to fall foul of US FDA

14-03-2014

Even as India-based drug majors Ranbaxy and Wockhardt reel under the impact of US Food and Drug Administration…

Asia-PacificGenericsIndiaProductionRegulation

Ranbaxy temporarily suspends shipments from Toansa and Dewas plants

25-02-2014

Indian drugmaker Ranbaxy Laboratories has announced in a letter to the Stock Exchange that it has temporarily…

Asia-PacificDaiichi SankyoGenericsIndiaProductionRanbaxy Laboratories

Another ban by US FDA on a Ranbaxy production facility

Another ban by US FDA on a Ranbaxy production facility

24-01-2014

As if the Indian drug major has not had enough negative news from the US regulator, the US Food and Drug…

Asia-PacificDaiichi SankyoGenericsIndiaNorth AmericaProductionRanbaxy LaboratoriesRegulationUSA

Russia, Ukraine and the Baltic states increasing in importance on the contract manufacturing market

Russia, Ukraine and the Baltic states increasing in importance on the contract manufacturing market

11-12-2013

Russia seems to be an attractive country for pharmaceutical contract manufacturing, chiefly because of…

Asia-PacificChinaEastern EuropeGenericsIndiaProductionRegulationRussiaUkraine

Ban on FDA-regulated drugs from Ranbaxy's Mohali plant

17-09-2013

There was another blow for India's largest drugmaker Ranbaxy Laboratories (BSE: 500359) yesterday (September…

Asia-PacificDaiichi SankyoGenericsNorth AmericaProductionRanbaxy LaboratoriesRegulation

Strategic alliance for pharmaceutical contract research and manufacturing in China

07-08-2013

Taiwanese active pharmaceutical ingredients (APIs) maker ScinoPharm (Changshu) Pharmaceuticals (TSE:…

Asia-PacificGenericsProductionResearchScinoPharmSundai MediTech

Leading Indian drugmakers eye pharma production in Russia

08-07-2013

Several top Indian drugmakers and suppliers, including Dr Reddy's (NYSE: RDY), Ranbaxy (BSE: 500359),…

Asia-PacificAurobindo PharmaCiplaDr Reddy's LaboratoriesEuropeGenericsProductionRanbaxy Laboratories

China forms global alliance with Germany's blue inspection for drug quality

11-06-2013

Effective June 1, 2013, the China Chamber of Commerce for Import & Export of Medicines & Health Products…

Asia-PacificEuropeGenericsPharmaceuticalProductionRegulation

US DoJ says Ranbaxy pleads guilty and agrees to pay $500 million in settlements

14-05-2013

In the largest drug safety settlement to date with a generic drug manufacturer, Ranbaxy USA, a subsidiary…

Asia-PacificDaiichi SankyoFinancialGenericsLegalNorth AmericaProductionRanbaxy LaboratoriesRegulation

Africa's pharmaceutical industry faces numerous challenges, VoA reports

13-05-2013

Providing Africans with affordable health care could be realized if pharmaceutical products were produced…

Asia-PacificGenericsHealthcarePharmaceuticalProductionRest of the World

ScinoPharm Taiwan and Coland in strategic alliance for generic oncology injectables

10-05-2013

ScinoPharm Taiwan (TSE: 1789.TW) and Coland Holdings (TSE: 4144.TW) have formed a strategic alliance…

Asia-PacificColandGenericsOncologyProductionScinoPharm

Sagent Pharma to buy remaining 50% stake in Chinese JV for $25 million

06-05-2013

US specialty pharmaceutical company Sagent Pharmaceuticals (Nasdaq: SGNT) has entered into an agreement…

Asia-PacificGenericsKanghong Sagent (Chengdu) PharmaceuticalMergers & AcquisitionsPharmaceuticalProductionSagent Pharmaceuticals

Neuland Labs in deal with Mitsubishi unit to strengthen Japanese position

12-03-2013

Indian active pharmaceutical ingredients maker Neuland Laboratories (BO:524558) has announced a manufacturing…

API CorpAsia-PacificGenericsMitsubishi ChemicalNeuland LaboratoriesProduction

Indian Pharma growth outpaces rivals, but must embrace innovation

12-03-2013

Ranking among the top five globally by production volume, the Indian pharmaceutical market at present…

Asia-PacificBiotechnologyGenericsMarkets & MarketingPharmaceuticalProductionResearch

Pharmaceutical manufacturing in China worth $78.8 billion in 2012, says IBISWorld

04-02-2013

Revenue for the pharmaceutical manufacturing industry in China is expected to increase at an annualized…

Asia-PacificGenericsPharmaceuticalProduction

ScinoPharm and Foresee Pharma set up JV for novel oncological peptide drugs

31-01-2013

Taiwanese drugmaker ScinoPharm (TWSE: 1789) and Foresee Pharmaceuticals, a Delaware, USA-based spin-out…

Asia-PacificForesee PharmaceuticalsGenericsleuprolideOncologyPharmaceuticalProductionResearchScinoPharm

China now one of the world's largest heparin API producers and exporters; report

13-01-2013

China, abundant in heparin raw materials, has become one of the world's largest heparin API producers…

Asia-PacificCardio-vascularGenericsheparinMarkets & MarketingPharmaceuticalProduction

Australia's pharma sector a net importer but also one of its largest high-tech exporters

13-01-2013

The pharmaceutical product manufacturing industry in Australia is dominated by major global pharmaceutical…

Asia-PacificBiotechnologyGenericsMarkets & MarketingPharmaceuticalProduction

Catalent and UMN Pharma collaborate for biosimilars development and production in Japan

16-12-2012

Privately-held USA-based Catalent Pharma Solutions and Japanese drugmaker UMN Pharma (TYO Mothers: 4585)…

Asia-PacificBiotechnologyCatalent Pharma SolutionsGenericsProductionResearchUMN PharmaVaccines

"India Pharma Inc" gearing up for the next level of growth

05-11-2012

Indian pharmaceutical companies will have to rethink business strategy in the light of several interventions…

Asia-PacificGenericsHealthcareMarkets & MarketingPharmaceuticalPricingProductionRegulation

Biopharmaceuticals promise to boost downstream processing in Asia

04-11-2012

Global contract manufacturing organizations (CMOs) are set to steadily become more and more popular,…

Asia-PacificBiotechnologyGenericsPharmaceuticalProduction

Australian Pharma sees opportunities in govt "Asian Century" report

30-10-2012

The government's Australia in the Asian Century report, released this week, highlights the opportunity…

Asia-PacificGenericsMarkets & MarketingPharmaceuticalProductionResearch

Taiwan beats Japan and South Korea to PIC/S membership

19-10-2012

Taiwan's Food and Drug Administration of the Department of Health has finally succeeded in knocking the…

Asia-PacificGenericsPharmaceuticalProductionRegulation

Mylan buys Indian production unit from SMS Pharma for $33 million

18-10-2012

Following speculation that started last month, India's SMS Pharmaceuticals this week confirmed that it…

Asia-PacificGenericsMergers & AcquisitionsMylan LaboratoriesProductionSMS Pharmaceuticals

1 to 25 of 29 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top